<SEC-DOCUMENT>0001104659-22-022672-index.html : 20220214 <SEC-HEADER>0001104659-22-022672.hdr.sgml : 20220214 <ACCEPTANCE-DATETIME>20220214160416 ACCESSION NUMBER: 0001104659-22-022672 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 GROUP MEMBERS: CORRIENTE MASTER FUND II, LP GROUP MEMBERS: MARK L. HART III SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80378 FILM NUMBER: 22631288 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Corriente Advisors, LLC CENTRAL INDEX KEY: 0001406718 IRS NUMBER: 752939516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1401 FOCH ST STREET 2: SUITE 100 CITY: FORT WORTH STATE: TX ZIP: 76107 BUSINESS PHONE: 8178700400 MAIL ADDRESS: STREET 1: 1401 FOCH ST STREET 2: SUITE 100 CITY: FORT WORTH STATE: TX ZIP: 76107 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>tm226234d1_sc13ga.htm <DESCRIPTION>SC 13G/A <TEXT> Document 1 - file: tm226234d1_sc13ga.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.A <SEQUENCE>2 <FILENAME>tm226234d1_ex99-a.htm <DESCRIPTION>EXHIBIT 99.A <TEXT> Document 2 - file: tm226234d1_ex99-a.htm
</DOCUMENT> </SEC-DOCUMENT>